According to Fortune Business Insights, the global diabetes treatment devices market was valued at USD 10.83 billion in 2018 and is projected to reach USD 22.83 billion by 2032, exhibiting a CAGR of 5.5% during the forecast period. In 2018, North America dominated the diabetes treatment devices market with a market share of 40.44%.
